drugset / Trial / NCT02247518

CKD-397 Drug-drug Interaction Study (A)

NCT02247518 ↗

Phase 1 Completed 16 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate to effect of tamsulosin on the pharmacokinetic properties of tadalafil

Timeline

Start
2014-09
Primary completion
2014-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cialis Tab. 5mg Unknown 5 mg Oral
Subject Harnal-D Cap. 0.2mg Unknown 0.2 mg Oral

Indications

No indication recorded.